Search - tctmd.com

Displaying 981 - 1000 of 1417

Sort: Relevancy | Date

News Daily News

Registry Finds Wide Variation in Exclusion of STEMI Patients from D2B Time Reporting

April 28, 2014

News Industry News

Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease

April 28, 2014

News Industry News

Edwards Lifesciences Comments on U.S. Appeals Court Order

April 21, 2014

News Daily News

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Yael L. Maxwell

April 17, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

Presentation ECHO 2014

Systolic Heart Failure: Review of Cardiomyopathies

Presenter: Michael H. Picard

April 10, 2014

Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

News Industry News

EDWARDS INTUITY Elite Valve System Receives CE Mark

April 04, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

Presentation Physiology and Intravascular Imaging 2014

Evaluation of Left Main Stenosis ALWAYS Requires Hemodynamic Assessment

Presenter: Michael J. Lim

March 28, 2014

News Industry News

Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Daily News

El Flujo Colateral Influye en la Reperfusión y en los Resultados de los ACV Isquémicos Agudos

March 13, 2014

News Daily News

Collateral Flow Impacts Reperfusion, Outcome in Acute Ischemic Stroke

March 13, 2014

Presentation

Effect of Collateral Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke

Presenter: Michael P. Marks

March 10, 2014

Presentation CTO 2014

The Current CTO Toolbox and Regional Availability

Presenter: R. Michael Wyman

February 27, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Advertisement

Registry Finds Wide Variation in Exclusion of STEMI Patients from D2B Time Reporting

Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease

Edwards Lifesciences Comments on U.S. Appeals Court Order

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Systolic Heart Failure: Review of Cardiomyopathies

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

EDWARDS INTUITY Elite Valve System Receives CE Mark

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Evaluation of Left Main Stenosis ALWAYS Requires Hemodynamic Assessment

Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

El Flujo Colateral Influye en la Reperfusión y en los Resultados de los ACV Isquémicos Agudos

Collateral Flow Impacts Reperfusion, Outcome in Acute Ischemic Stroke

Effect of Collateral Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke

The Current CTO Toolbox and Regional Availability

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content